Market Research Logo

US Procedure Numbers for Gastrointestinal Devices 2017 - MedPro

US Procedure Numbers for Gastrointestinal Devices 2017 - MedPro

The U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. The largest segment in the total GI endoscopic device market was the GI flexible endoscope segment. This segment represented approximately 24.5% of the total market in 2016. The relatively large size of this segment is due to a combination of relatively high average selling price (ASP) coupled with relatively short life-span of five years, resulting in constant renewal of the equipment. One of the main drivers in this market is the growth in the procedure numbers, such as colonoscopy and therapeutic ERCP. Colonoscopy has become a gold-standard in the colorectal cancer screening program, with more than 18 million procedures performed annually. A lot of devices discussed in this report are used in conjunction with the each other, thus having a multiplication effect on the size of the market with each extra procedure performed.

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.


EXECUTIVE SUMMARY
U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
1.1 KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 GASTROINTESTINAL DISEASE: TREATMENT AND DIAGNOSTICS
2.2.1 Gastro-Esophageal Reflux Disease (GERD)
2.2.2 Barrett's Esophagus
2.2.3 Digestive Cancer
2.2.4 Gastrointestinal bleeding
2.2.5 Bile Duct Disorders
2.2.6 Crohn’s disease
2.2.7 Ulcer
2.2.8 Ogilvie Syndrome or Intestinal Pseudo-Obstruction
2.3 PATIENT DEMOGRAPHICS
2.3.11 Patient Demographics
2.3.11.1 All Digestive Diseases
2.3.11.2 Abdominal Wall Hernia
2.3.11.3 Chronic Constipation
2.3.11.4 Diverticular Disease
2.3.11.5 Prescriptions
2.3.11.6 Gastroesophageal Reflux Disease
2.3.11.7 Gastrointestinal Infections
2.3.11.8 Hemorrhoids
2.3.11.9 Inflammatory Bowel Disease
2.3.11.10 Liver Disease
2.3.11.11 Pancreatitis
2.3.11.12 Peptic Ulcer Diseases
2.3.12 Digestive Cancer
GASTROINTESTINAL PROCEDURE NUMBERS
3.1 LIST OF PROCEDURAL CODES
3.2 PROCEDURE OVERVIEW
3.2.1 Total Gastrointestinal Device Market Procedures
3.2.2 Gastrointestinal Endoscopy Procedures by Segment
3.2.2.1 EGD Procedures
3.2.2.2 Colonoscopy Procedures
3.2.2.3 Sigmoidoscopy Procedures
3.2.2.4 Enteroscopy Procedures
3.2.2.5 Ultrasound Endoscopy Procedures
3.2.2.6 ERCP Procedures
3.2.3 Capsule Endoscopy Procedures
3.2.4 Virtual Colonoscopy Procedures
3.2.5 Stenting Procedures by Segment
3.2.5.1 Esophageal Stenting Procedures
3.2.5.2 Duodenal Stenting Procedures
3.2.5.3 Colonic Stenting Procedures
3.2.5.4 Biliary Stenting Procedures
3.2.6 Dilation Procedures by Segment
3.2.6.1 Esophageal Dilation Procedures
3.2.6.2 Duodenal Dilation Procedures
3.2.6.3 Colonic Dilation Procedures
3.2.6.4 Biliary Dilation Procedures
3.2.7 Tissue Biopsy Procedures by Segment
3.2.7.1 Biopsy Forceps Procedures
3.2.7.2 EUS Needle Procedures
3.2.8 Snare, Tumor and Polyp Removal Procedures
3.2.9 Specimen Retrieval Procedures
3.2.10 Foreign Body Removal Procedures
3.2.11 Hemostasis Procedures
3.2.12 Enteral Feeding Tube Placement Procedures
3.2.13 Anti-Reflux Device Implantation Procedures
3.2.14 Barrett's Esophagus Ablation Procedures
ABBREVIATIONS
List of Charts
Chart 1 1: Gastrointestinal Endoscopic Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Gastrointestinal Endoscopic Device Market Overview, U.S., 2016 & 2023
Chart 2 1: Male Incidence, Digestive Cancer, U.S., 2016
Chart 2 2: Male Deaths, Digestive Cancer, U.S., 2016
Chart 2 3: Female Incidence, Digestive Cancer, U.S., 2016
Chart 2 4: Female Deaths, Digestive Cancer, U.S., 2016
Chart 3 1: Total Gastrointestinal Device Market Procedure Numbers, U.S., 2013 – 2023
Chart 3 2: Gastrointestinal Endoscopy Procedure Numbers by Segment, U.S., 2013 – 2023
Chart 3 3: Capsule Endoscopy Procedure Numbers, U.S., 2013 – 2023
Chart 3 4: Virtual Colonoscopy Procedure Numbers, U.S., 2013 – 2023
Chart 3 5: Stenting Procedure Numbers by Segment, U.S., 2013 – 2023
Chart 3 6: Dilation Procedure Numbers by Segment, U.S., 2013 – 2023
Chart 3 7: Tissue Biopsy Procedure Numbers by Segment, U.S., 2013 – 2023
Chart 3 8: Snare, Tumor and Polyp Removal Procedure Numbers, U.S., 2013 – 2023
Chart 3 9: Specimen Retrieval Procedure Numbers, U.S., 2013 – 2023
Chart 3 10: Foreign Body Removal Procedure Numbers, U.S., 2013 – 2023
Chart 3 11: Hemostasis Procedure Numbers, U.S., 2013 – 2023
Chart 3 12: Enteral Feeding Tube Placement Procedure Numbers, U.S., 2013 – 2023
Chart 3 13: Anti-Reflux Device Implantation Procedure Numbers, U.S., 2013 – 2023
Chart 3 14: Barrett's Esophagus Ablation Procedure Numbers, U.S., 2013 – 2023
List of Figures
Figure 1 1: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 2)
Figure 1 2: Gastrointestinal Endoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2016
Figure 1 4: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (1 of 2)
Figure 1 5: Factors Impacting the Gastrointestinal Endoscopic Device Market by Segment, U.S. (2 of 2)
Figure 1 6: Recent Events in the Gastrointestinal Endoscopic Device Market, U.S., 2012 – 2016
Figure 1 7: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016
Figure 1 8: Procedure Codes Investigated, U.S., 2016
Figure 1 9: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (1 of 4)
Figure 1 10: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (2 of 4)
Figure 1 11: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (3 of 4)
Figure 1 12: Gastrointestinal Endoscopic Device Markets Covered, U.S., 2016 (4 of 4)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 2 1: Leading Physician Diagnoses for GI Disorders, U.S., 2009
Figure 2 2: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (1 of 2)
Figure 2 3: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 – 2010 (2 of 2)
Figure 2 4: Digestive Cancer Statistics by Type and Gender, U.S., 2016
Figure 3 1: Procedural Codes Investigated, U.S., 2016
Figure 3 2: Procedural Numbers by Segment, U.S., 2016 (1 out of 3)
Figure 3 3: Procedural Numbers by Segment, U.S., 2016 (2 out of 3)
Figure 3 4: Procedural Numbers by Segment, U.S., 2016 (3 out of 3)
Figure 3 5: Gastrointestinal Endoscopy Procedures by Segments, U.S., 2016 (1 of 2)
Figure 3 6: Gastrointestinal Endoscopy Procedures by Segments, U.S., 2016 (2 out of 2)
Figure 3 7: Capsule Endoscopy Procedure Numbers, U.S., 2013 – 2023
Figure 3 8: Virtual Colonoscopy Procedure Numbers, U.S., 2013 – 2023
Figure 3 9: Stenting Procedures by Segments, U.S., 2016 (1 out of 2)
Figure 3 10: Stenting Procedures by Segments, U.S., 2016 (2 out of 2)
Figure 3 11: Dilation Procedures by Segments, U.S., 2016 (1 out of 2)
Figure 3 12: Dilation Procedures by Segments, U.S., 2016 (2 out of 2)
Figure 3 13: Tissue Biopsy Procedures by Segments, U.S., 2016
Figure 3 14: Snare, Tumor and Polyp Removal Procedure Numbers, U.S., 2013 – 2023
Figure 3 15: Specimen Retrieval Procedure Numbers, U.S., 2013 – 2023
Figure 3 16: Foreign Body Removal Procedure Numbers, U.S., 2013 – 2023
Figure 3 17: Hemostasis Procedure Numbers, U.S., 2013 – 2023
Figure 3 18: Enteral Feeding Tube Placement Procedure Numbers, U.S., 2013 – 2023
Figure 3 19: Anti-Reflux Device Implantation Procedure Numbers, U.S., 2013 – 2023
Figure 3 20: Barrett's Esophagus Ablation Procedure Numbers, U.S., 2013 – 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report